Name: preparation and analysis of in vitro three dimensional breast carcinoma surrogates
Uploaded: 2016-05-09T15:00:00.000+00:00
Duration: 8 min 16 s
Description: Watch this Scientific Journal Video about Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates at JoVE.com

The University of Alabama at Birmingham Center for Metabolic Bone Disease performed the histologic processing and sectioning of surrogates. Southern Research (Birmingham, AL) provided support for the manufacture of the bioreactor system. Funding was provided by the United States Department of Defense Breast Cancer Research Program (BC121367).

<ol>
	<li>Hakanson, M., Textor, M., Charnley, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Engineered+3D+environments+to+elucidate+the+effect+of+environmental+parameters+on+drug+response+in+cancer.">Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer.</a> Integr Biol (Camb). 3 (1), 31-38 (2011).</li><li>Horning, J. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=3-D+tumor+model+for+in+vitro+evaluation+of+anticancer+drugs.">3-D tumor model for in vitro evaluation of anticancer drugs.</a> Mol Pharm. 5 (5), 849-862 (2008).</li><li>Dhiman, H. K., Ray, A. R., Panda, A. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Three-dimensional+chitosan+scaffold-based+MCF-7+cell+culture+for+the+determination+of+the+cytotoxicity+of+tamoxifen.">Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.</a> Biomaterials. 26 (9), 979-986 (2005).</li><li>Place, A. E., Jin Huh, S., Polyak, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+microenvironment+in+breast+cancer+progression:+biology+and+implications+for+treatment.">The microenvironment in breast cancer progression: biology and implications for treatment.</a> Breast Cancer Res. 13 (6), 227 (2011).</li><li>Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., Wang, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Stromal+cells+in+tumor+microenvironment+and+breast+cancer.">Stromal cells in tumor microenvironment and breast cancer.</a> Cancer Metastasis Rev. 32 (1-2), 303-315 (2013).</li><li>Paulsson, J., Micke, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prognostic+relevance+of+cancer-associated+fibroblasts+in+human+cancer.">Prognostic relevance of cancer-associated fibroblasts in human cancer.</a> Semin Cancer Biol. 25, 61-68 (2014).</li><li>Roskelley, C. D., Desprez, P. Y., Bissell, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extracellular+matrix-dependent+tissue-specific+gene+expression+in+mammary+epithelial+cells+requires+both+physical+and+biochemical+signal+transduction.">Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction.</a> Proc. Natl. Acad. Sci. 91, 12378-12382 (1994).</li><li>Pickl, M., Ries, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comparison+of+3D+and+2D+tumor+models+reveals+enhanced+HER2+activation+in+3D+associated+with+an+increased+response+to+trastuzumab.">Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab.</a> Oncogene. 28 (3), 461-468 (2008).</li><li>Ivascu, A., Kubbies, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+generation+of+single-tumor+spheroids+for+high-throughput+cell+function+and+toxicity+analysis.">Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis.</a> J Biomol Screen. 11 (8), 922-932 (2006).</li><li>Lovitt, C. J., Shelper, T. B., Avery, V. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Advanced+cell+culture+techniques+for+cancer+drug+discovery.">Advanced cell culture techniques for cancer drug discovery.</a> Biology (Basel). 3 (2), 345-367 (2014).</li><li>Bergamaschi, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extracellular+matrix+signature+identifies+breast+cancer+subgroups+with+different+clinical+outcome.">Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.</a> J Pathol. 214 (3), 357-367 (2008).</li><li>Oskarsson, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extracellular+matrix+components+in+breast+cancer+progression+and+metastasis.">Extracellular matrix components in breast cancer progression and metastasis.</a> The Breast. 22, S66-S72 (2013).</li><li>Kelley, L. C., Lohmer, L. L., Hagedorn, E. J., Sherwood, D. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Traversing+the+basement+membrane+in+vivo:+A+diversity+of+strategies.">Traversing the basement membrane in vivo: A diversity of strategies.</a> JBC. 204 (3), 291-301 (2014).</li><li>Sadlonova, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Breast+fibroblasts+modulate+epithelial+cell+proliferation+in+three-dimensional+in+vitro+co-culture.">Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture.</a> Breast Cancer Res. 4, (2004).</li><li>Wendt, D., Marsano, A., Jakob, M., Heberer, M., Martin, I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oscillating+perfusion+of+cell+suspensions+through+three-dimensional+scaffolds+enhances+cell+seeding+efficiency+and+uniformity.">Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity.</a> Biotechnol Bioeng. 84 (2), 205-214 (2003).</li><li>Marshall, L. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Flow-perfusion+bioreactor+system+for+engineered+breast+cancer+surrogates+to+be+used+in+preclinical+testing.">Flow-perfusion bioreactor system for engineered breast cancer surrogates to be used in preclinical testing.</a> J Tissue Eng Regen Med. , (2015).</li><li>Calcagnile, P., Fragouli, D., Mele, E., Ruffilli, R., Athanassiou, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Polymeric+foams+with+functional+nanocomposite+cells.">Polymeric foams with functional nanocomposite cells.</a> RSC Adv. 4, 19177-19182 (2014).</li><li>Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., Hynes, R. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extracellular+matrix+signatures+of+human+mammary+carcinoma+identify+novel+metastasis+promoters.">Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.</a> eLife. 3, (2014).</li><li>Lochter, A., Bissell, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Involvement+of+extracellular+matrix+constituents+in+breast+cancer.">Involvement of extracellular matrix constituents in breast cancer.</a> Semin Cancer Biol. 6 (3), 165-173 (1995).</li><li>Joiner, K. S., Spangler, E. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+of+HistoGel-embedded+specimens+for+use+in+veterinary+diagnostic+pathology.">Evaluation of HistoGel-embedded specimens for use in veterinary diagnostic pathology.</a> J Vet Diagn Invest. 24 (4), 710-715 (2012).</li><li>Varsegi, G. M., Shidham, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cell+Block+Preparation+from+Cytology+Specimen+with+Predominance+of+Individually+Scattered+Cells.">Cell Block Preparation from Cytology Specimen with Predominance of Individually Scattered Cells.</a> J Vis Exp. (29), e1316 (2009).</li><li>Sadlonova, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+Breast+Fibroblasts+Inhibit+Growth+of+the+MCF10AT+Xenograft+Model+of+Proliferative+Breast+Disease.">Human Breast Fibroblasts Inhibit Growth of the MCF10AT Xenograft Model of Proliferative Breast Disease.</a> Am J Pathol. 170 (3), (2007).</li><li>Otali, D., He, Q., Stockard, C. R., Grizzle, W. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Preservation+of+immunorecognition+by+transferring+cells+from+10%+neutral+buffered+formalin+to+70%+ethanol.">Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol.</a> Biotech Histochem. 88, 170-180 (2013).</li><li>Webster, S. S., Jenkins, L., Burg, K. J. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Histological+Techniques+for+Porous,+Absorbable,+Polymeric+Scaffolds,+Used+in+Tissue+Engineering.">Histological Techniques for Porous, Absorbable, Polymeric Scaffolds, Used in Tissue Engineering.</a> J Histotechnol. 26 (1), 57-65 (2003).</li><li>Troy, T. -. C., Arabzadeh, A., Enikanolaiye, A., Lariviere, N., Turksen, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Immunohistochemistry+on+Paraffin+Sections+of+Mouse+Epidermis+Using+Fluorescent+Antibodies.">Immunohistochemistry on Paraffin Sections of Mouse Epidermis Using Fluorescent Antibodies.</a> J Vis Exp. (11), (2008).</li><li>Carpenter, A. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CellProfiler:+image+analysis+software+for+identifying+and+quantifying+cell+phenotypes.">CellProfiler: image analysis software for identifying and quantifying cell phenotypes.</a> Genome Biol. 7 (10), R100 (2006).</li><li>Kwon, Y. -. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gli1+enhances+migration+and+invasion+via+up-regulation+of+MMP-11+and+promotes+metastasis+in+ERa+negative+breast+cancer+cell+lines.">Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERa negative breast cancer cell lines.</a> Clin Exp Metastasis. (28), (2011).</li><li>Evilsizor, M. N., Ray-Jones, H. F., Lifshitz, J., Ziebell, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Primer+for+Immunohistochemistry+on+Cryosectioned+Rat+Brain+Tissue:+Example+Staining+for+Microglia+and+Neurons.">Primer for Immunohistochemistry on Cryosectioned Rat Brain Tissue: Example Staining for Microglia and Neurons.</a> J Vis Exp. (99), e52293 (2015).</li><li>Pal, A., Kleer, C. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Three+dimensional+cultures:+a+tool+to+study+normal+acinar+architecture+vs.+malignant+transformation+of+breast+cells.">Three dimensional cultures: a tool to study normal acinar architecture vs. malignant transformation of breast cells.</a> J Vis Exp. (86), e51311 (2014).</li><li>Hasselbach, L. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optimization+of+High+Grade+Glioma+Cell+Culture+from+Surgical+Specimens+for+Use+in+Clinically+Relevant+Animal+Models+and+3D+Immunochemistry.">Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry.</a> J Vis Exp. (83), e51088 (2014).</li><li>Foty, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Simple+Hanging+Drop+Cell+Culture+Protocol+for+Generation+of+3D+Spheroids.">A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids.</a> J Vis Exp. (51), e2720 (2011).</li><li>Materne, E. -. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Multi-organ+Chip+-+A+Microfluidic+Platform+for+Long-term+Multi-tissue+Coculture.">The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture.</a> J Vis Exp. (98), e52526 (2015).</li><li>Sadlonova, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+of+Molecular+Distinctions+Between+Normal+Breast-Associated+Fibroblasts+and+Breast+Cancer-Associated+Fibroblasts.">Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts.</a> Cancer Microenviron. 2, 9-21 (2009).</li><li>Wang, J. D., Douville, N. J., Takayama, S., ElSayed, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantitative+analysis+of+molecular+absorption+into+PDMS+microfluidic+channels.">Quantitative analysis of molecular absorption into PDMS microfluidic channels.</a> Ann Biomed Eng. 40 (9), 1862-1873 (2012).</li><li>Halldorsson, S., Lucumi, E., Gomez-Sjoberg, R., Fleming, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Advantages+and+challenges+of+microfluidic+cell+culture+in+polydimethylsiloxane+devices.">Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices.</a> Biosens Bioelectron. 63, 218-231 (2015).</li><li>Regehr, K. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biological+implications+of+polydimethylsiloxane-based+microfluidic+cell+culture.">Biological implications of polydimethylsiloxane-based microfluidic cell culture.</a> Lab Chip. 9 (15), 2132-2139 (2009).</li><li>Burdett, E., Kasper, F. K., Mikos, A. G., Ludwig, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Engineering+tumors:+a+tissue+engineering+perspective+in+cancer+biology.">Engineering tumors: a tissue engineering perspective in cancer biology.</a> Tissue Eng Part B Rev. 16 (3), 351-359 (2010).</li><li>Caruso, R. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+of+coagulative+necrosis+in+malignant+epithelial+tumors+(Review).">Mechanisms of coagulative necrosis in malignant epithelial tumors (Review).</a> Oncol Lett. 8 (4), 1397-1402 (2014).</li><li>Elmore, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Apoptosis:+A+Review+of+Programmed+Cell+Death.">Apoptosis: A Review of Programmed Cell Death.</a> Toxicol Pathol. 35 (4), 495-516 (2007).</li><li>Majno, G., Joris, I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Apoptosis,+oncosis,+and+necrosis.+An+overview+of+cell+death.">Apoptosis, oncosis, and necrosis. An overview of cell death.</a> Am J Pathol. 146 (1), 3-15 (1995).</li><li>Ogino, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+pathological+epidemiology+of+epigenetics:+emerging+integrative+science+to+analyze+environment,+host,+and+disease.">Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.</a> Mod Pathol. 26 (4), 465-484 (2013).</li><li>Otali, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Combined+effects+of+formalin+fixation+and+tissue+processing+on+immunorecognition.">Combined effects of formalin fixation and tissue processing on immunorecognition.</a> Biotech Histochem. 84 (5), 223-247 (2009).</li></ol>

The authors declare that they have no competing financial interests.

При этом метод 3D культуры было описано, что включает в себя компоненты микроокружения ткани, в том числе внеклеточного матрикса (ЕСМ) и фибробластами стромы человека, в объеме, который более точно модели рака молочной железы человека, чтобы позволить для разработки суммирующий 3D морфол...

Трехмерные модели (3D) культуры , которая более точно имитируют архитектуру опухоли и микросреду в естественных условиях имеют важное значение для исследований , направленных рассекать сложных взаимодействий между клетками и их микросреды и проверить эффективность терапии кандидата. Опухоль мерность воздействия кислорода и питательных градиенты, равномерность воздействия лекарственного средства, интерстициальный потока давления / крови, и 3D архитектуры 1-4. Наличие соответствующего стромы микросреды способствует размерностью опухоли и оказывает влияние на клеточной сигнализации-ECM и паракринной сигнализации между клетками стромы и злокачественные эпителиальные клетки. Эффекты размерностью опухоли и микросреды на клеточной функции хорошо установлены, с обоими факторами , изменяющих реакцию снадобья 1,3,5-8. Кроме того, кинетика клеточного роста, скорости метаболизма и клеточной сигнализации различаются между двухмерной (2D) культуры и культуры в 3D, с учетом этих факторов AFFEcting клеточный ответ 1,3,8-10. В пробирке, опухоль суррогатной микросреда может модулироваться включая репрезентативные ЕСМ компоненты и популяции стромальных клеток. Злокачественные эпителиальные клетки находятся под влиянием ECM и рак связаны стромальных клеток либо в синергетической / защитной манере способствовать прогрессии опухоли или в подавляющей способом для ингибирования дальнейшего распространения опухоли 5,6,10. В любом контексте, строма может повлиять на терапевтический ответ и доставки лекарственного средства посредством сигнализации паракринной и / или путем увеличения интерстициального давления в опухоли приводит к снижению доставки лекарств 1,6. Таким образом, добавление внеклеточного матрикса и клеток стромы в доклинических моделей поможет резюмировать аспекты опухоли, которые не могут быть смоделированы хорошо в 2D культуре. При этом способ установить рака молочной железы суррогаты, которые включают обзорном микросреду, в том числе ECM компонентов и сtromal клетки, в 3D-объеме описывается. При раке молочной железы, популяция стромальных клеток преимущественно состоит из раковых ассоциированных фибробластов (CAF) и стромы ECM в основном состоит из I типа коллагена с меньшим долей матричных компонентов, которые находятся в базальной мембране, в том числе ламинин и коллагена типа IV 1,4,11-13. Таким образом, эти компоненты карциномы молочной железы микросреды (т.е., CAF, коллаген I, и базальную мембрану), были включены в суррогатов. Этот метод может быть использован для получения твердых, не-перфузию 3D индикатору (Фигура 1А) , или могут быть адаптированы для включения перфузию среды через суррогат через систему биореактора (Фиг.1В). Оба подхода описаны здесь. Этот метод также может быть модифицирован, чтобы включать в себя другие элементы стромы, такие как опухоль-ассоциированных макрофагов, или моделировать другие твердые опухоли, регулируя клеточные и ECM компонентов, в зависимости от обстоятельств. <pкласс = &quot;jove_content&quot;&gt; Для карциномы молочной железы суррогата описано здесь, мы использовали МДА-МВ-231 (231) молочной линии раковых клеток, АКР ранее выделенный из человеческой карциномы 14 молочной железы, и ЕСМ состоит из 90% коллагена I ( фактор роста мембранного материала снижается подвальный 6 мг / мл) и 10% (БМ). Суррогатная либо выращивают в 8-а камера скольжения (твердый суррогата) или система биореактора используется для обеспечения непрерывного питательный перфузию (перфузировались суррогатной). Любая система проточном биореакторе , который может вместить объем ЕСМ , содержащий клетки , могут быть использованы 15. В качестве примера, мы описываем получение суррогатов ткани в нашей системе биореактора. Эта система была разработана в доме и не является коммерчески доступным. Потому что наше внимание здесь уделяется подготовке и анализу суррогатами 3D тканей, мы не пошли в обширную подробно о специфике производства и сборки нашей системы биореактора. Тем не менее, подробное описаниеэта система и ее развитие было опубликовано 16. В этом биореакторе системе, проточный канал полидиметилсилоксан (PDMS) используется для размещения суррогат, который поддерживается с помощью PDMS пены (формируется с использованием методов , аналогичных тем , которые описаны Calcagnile и др. 17). Этот объем пронизана 4 микроканалов (каждый из которых 400 мкм в диаметре), которые непрерывно увлажненную среды через microphysiologic насос для подачи кислорода и питательных веществ к суррогат. Соответствующий анализ суррогатами имеет решающее значение, чтобы получить необходимую информацию относительно клеточной функции в ответ на лечение или других манипуляций. Суррогаты могут быть проанализированы различными способами, в том числе прямой визуализации интактных суррогатов с помощью конфокальной микроскопии или другие средства неинвазивной визуализации, непрямой клеточный анализ путем анализа кондиционированной среды или перфузат, секретируемые продукты или анализа на гистологических участков после фиксации и обработки кпарафин. Одним из таких параметров, которые могут быть оценены на гистологических препаратов является плотность клеток. Приведем один подход к измерению плотности клеток (то есть, число ядросодержащих клеток на площадь поперечного сечения) с использованием полуавтоматических методов обработки изображений , применяемые к микрофотографий суррогатных гистологических срезах , окрашенных гематоксилином и эозином (H &amp; E). Плотность клеток может быть использована в качестве индикатора относительного изменения количества клеток в течение долгого времени, или, что является результатом различных условиях роста и обработок. <img alt="Рисунок 1" src="/files/ftp_upload/54004/54004fig1.jpg" /> Рисунок 1. Объем 3D и система биореактора. А) Схема процесса для создания 3D твердых суррогаты. Топ: мультфильм 3D твердого объема, содержащего ECM (розовый), эпителиальные клетки карциномы (желтые) и CAF (оранжевый); Внизу:. Вид сверху 8-а камера слайд - содержащих суррогатами B) Схема процесса для генерации перфузировались 3D суррогаты. Топ: чаrtoon 3D-объема с каналами для обеспечения средней перфузии и содержащий ECM (розовый), эпителиальные клетки карциномы (желтый) и CAF (оранжевый); Средний: изображение канала потока, содержащего PDMS PDMS пены (черная стрелка), который будет введен с ячейкой + ECM и пронизана с полимерным покрытием из нержавеющей стальной проволоки (розовая стрелка) измерения 400 мкм в диаметре; Внизу:. Изображение проточного канала PDMS , содержащего суррогат и подсоединенного к системе биореактора , чтобы обеспечить сплошной среды перфузией (перистальтический насос и медиа - резервуар не показан) С) Изображения этапов обработки для обоих твердых и увлажненную суррогатами после культивирования. Слева: изображение cryomold, содержащего образец обработку геля и суррогатной; Средний: образ парафинового блока, содержащего фиксированный и обработанный суррогат; Справа:. Изображение стекло с H &amp; E-окрашенных гистологических раздел суррогата <a href="https://www.jove.com/files/ftp_upload/54004/54004fig1large.jpg" target="_blank">Пожалуйста</a> , <a href="https://www.jove.com/files/ftp_upload/54004/54004fig1large.jpg" target="_blank">нажмите здесь для просмотра</a>Большая версия этой фигуры.

<table><tbody><tr><td>Dulbecco&#039;s Modified Eagel Medium 1x (DMEM)</td><td>Corning CellGro</td><td>10-014-CV</td><td></td></tr><tr><td>Fetal Bovine Serum (FBS)</td><td>Atlanta Biologicals</td><td>S11150</td><td></td></tr><tr><td>0.25% Trypsin + 2.21&amp;nbsp;mM EDTA 1x</td><td>Corning</td><td>25-053-CI</td><td></td></tr><tr><td>Tissue Culture plates, 100&amp;nbsp;mm</td><td>CellTreat Scientific Products</td><td>229620</td><td>Sterile</td></tr><tr><td>Tissue Culture plates, 35&amp;nbsp;mm</td><td>CellTreat Scientific Products</td><td>229638</td><td>For PDMS foam formation&amp;nbsp;</td></tr><tr><td>9&quot; Glass pipette</td><td>Fisher&amp;nbsp;</td><td>13-678-20D</td><td>Sterile</td></tr><tr><td>10 ml pipette</td><td>CellTreat Scientific Products</td><td>229210B</td><td>Sterile</td></tr><tr><td>1,000 &amp;micro;l piptette tips</td><td>FisherBrand</td><td>02-717-166</td><td>Sterile Filtered</td></tr><tr><td>200 &amp;micro;l pipette tips</td><td>FisherBrand</td><td>02-717-141</td><td>Sterile Filtered</td></tr><tr><td>10 &amp;micro;l pipette tips</td><td>FisherBrand</td><td>02-717-158</td><td>Sterile Filtered</td></tr><tr><td>15 ml conical tubes</td><td>CellTreat Scientific Products</td><td>229410</td><td>Sterile</td></tr><tr><td>50 ml conical tubes</td><td>CellTreat Scientific Products</td><td>229422</td><td>Sterile</td></tr><tr><td>1.5 ml microcentrifuge tubes</td><td>FisherBrand</td><td>05-408-129</td><td>Sterile</td></tr><tr><td>Trypan blue</td><td>Corning Cellgro</td><td>25-900-CI</td><td>Sterile</td></tr><tr><td>Sylgard 184</td><td>Electron Microscopy Sciences</td><td>24236-10</td><td>PDMS elastomer and curing agent. Used for our in-house bioreactor.</td></tr><tr><td>PDMS Foam</td><td></td><td></td><td>Made in-house for use in our in-house bioreactor.</td></tr><tr><td>High Concentration Bovine Collagen Type I</td><td>Advanced Biomatrix</td><td>5133-A</td><td>FibriCol ~10 mg/ml</td></tr><tr><td>Growth Factor Reduced Matrigel (Basement Membrane)</td><td>Corning</td><td>354230</td><td>Basement membrane material</td></tr><tr><td>Sodium Bicarbonate</td><td>Sigma</td><td>S8761</td><td></td></tr><tr><td>Molecular Biology Grade Water</td><td>Fisher</td><td>BP2819-1</td><td></td></tr><tr><td>DMEM 10x&amp;nbsp;</td><td>Sigma-Aldrich</td><td>D2429</td><td></td></tr><tr><td>Nunc Lab-Tek Chamber Slide System&amp;nbsp;</td><td>Thermo Scientific</td><td>177402</td><td>8-well</td></tr><tr><td>Bioreactor</td><td></td><td></td><td>Made in-house.</td></tr><tr><td>Spring-Back 304 Stainless Steel&amp;mdash;Coated with PTFE polymer</td><td>McMaster-Carr</td><td>1749T19</td><td>Stainless steel wires to generate microchannels in our in-house&amp;nbsp; bioreactor system. 0.016&quot; Diameter</td></tr><tr><td>BioPharm Plus platinum-cured silicone pump tubing, L/S 14</td><td>Masterflex</td><td>EW-96440-14</td><td>For use in our in-house bioreactor system. Tubing ID: 1.6 mm, Hose barb size: 1/16 in.</td></tr><tr><td>2-Stop Tubing Sets, non-flared PVC, 1.52&amp;nbsp;mm ID</td><td>Cole-Parmer&amp;nbsp;</td><td>EW-74906-36</td><td>For use in our in-house bioreactor system (with microperistalitic pump).&amp;nbsp;</td></tr><tr><td>Six Channel precision micro peristaltic pump</td><td>Cole-Parmer</td><td>EW-74906-04</td><td>For use with our in-house bioreactor system</td></tr><tr><td>Tuberculin Syringes</td><td>BD Medical</td><td>309625</td><td>26 gauge 3/8 in. needle; Sterile</td></tr><tr><td>Dissecting Tissue Forceps</td><td>FisherBrand</td><td>13-812-36</td><td>5.5 inch</td></tr><tr><td>Mini Tube Rotator</td><td>Boekel Scientific</td><td>260750</td><td>Equipment option for surrogate rotation. Used with carousel for 50 ml tubes (model number 260753)</td></tr><tr><td>50 ml tube carousel</td><td>Boekel Scientific</td><td>260753</td><td>Used with mini tube rotator</td></tr><tr><td>Bambino&amp;nbsp; Hybridization Oven</td><td>Boekel Scientific</td><td>230301</td><td>Equipment option for surrogate rotation</td></tr><tr><td>HistoGel Specimen Processing Gel</td><td>Thermo Scientific</td><td>HG-4000-012</td><td>Specimen Processing Gel described in Step 5.2</td></tr><tr><td>Cryomold</td><td>Andwin Scientific</td><td>4566</td><td>15 mm x 15 mm x 5 mm</td></tr><tr><td>Tissue Marking Dye</td><td>Cancer Diagnostics, inc.&amp;nbsp;</td><td>03000P</td><td>Can be used to mark surrogates,&amp;nbsp; allowing multiple samples to be included in one tissue cassette&amp;nbsp;</td></tr><tr><td>Hinged tissue cassettes&amp;nbsp;</td><td>FisherBrand</td><td>22-272-416</td><td></td></tr><tr><td>Formalin</td><td>Fisher</td><td>23-245-685</td><td></td></tr><tr><td>GoldSeal Plain Glass Slides</td><td>Thermo Scientific</td><td>3048-002</td><td></td></tr><tr><td>Xylene</td><td>Fisher</td><td>X3P-1GAL</td><td></td></tr><tr><td>Ethanol, 200 proof (100%), USP</td><td>Decon Laboratories, Inc.</td><td>2805M</td><td></td></tr><tr><td>Hematoxylin</td><td>Thermo Scientific Richard-Allan Scientific</td><td>7211</td><td></td></tr><tr><td>Clarifier</td><td>Thermo Scientific Richard-Allan Scientific</td><td>7401</td><td></td></tr><tr><td>Bluing Solution</td><td>Thermo Scientific Richard-Allan Scientific</td><td>7301</td><td></td></tr><tr><td>Eosin Y</td><td>Thermo Scientific Richard-Allan Scientific</td><td>7111</td><td></td></tr><tr><td>Cytoseal XYL mounting media</td><td>Thermo Scientific Richard-Allan Scientific</td><td>83124</td><td></td></tr><tr><td>Coverslips</td><td>Fisher Scientific</td><td>12-548-5G</td><td></td></tr></tbody></table>

preparation and analysis of in vitro three dimensional breast carcinoma surrogates

Трехмерные (3D) культура является физиологически более соответствующий метод для моделирования поведения клеток в пробирке , чем двухмерной культуры. Карцином, включая карциномы молочной железы, представляют собой сложные 3D-ткани, состоящие из раковых эпителиальных клеток и компонентов стромы, включая фибробласты и внеклеточного матрикса (ЕСМ). Тем не менее , большинство моделей в пробирке клеток карциномы молочной железы состоят только из раковых эпителиальных клеток, опуская стромы и, следовательно, 3D архитектура опухоли в живом организме . Соответствующее 3D моделирование рака имеет важное значение для правильного понимания биологии опухоли, поведение и реакции на терапию. Тем не менее, продолжительность культуры и объема 3D-моделей ограничена наличием кислорода и питательных веществ в культуре. В данном случае мы демонстрируют способ, в котором рак молочной железы эпителиальные клетки и фибробластами стромы встроены в ECM для создания суррогат рака молочной железы 3D, которая включает в строму и могут быть выращены в качестветвердый 3D структуры или с помощью системы биореактора перфузионного для доставки кислорода и питательных веществ. После установки и начального периода роста, суррогаты могут быть использованы для доклинических испытаний лекарственных средств. В качестве альтернативы, клеточные и матричные компоненты суррогата могут быть модифицированы с целью решения различных биологических вопросов. После того, как культуры, суррогаты фиксируются и обрабатываются в парафин, в манере, подобной обработке образцов рака молочной железы клинические, для оценки параметров, представляющих интерес. Оценка одного такого параметра, плотность клеток, присутствующих, объясняется, где ImageJ и CellProfiler системы программного обеспечения для анализа изображений применяются к микрофотографии гистологических разделов суррогатов для количественного определения количества ядросодержащих клеток на единицу площади. Это может быть использовано в качестве индикатора изменения числа клеток с течением времени или изменение количества клеток в результате изменяющихся условий роста и обработок.

Цельных и перфузируемые 3D суррогаты рака молочной железы были получены, как описано выше, и выращивали в течение 7 дней. Впоследствии суррогаты фиксировались, обработаны парафином, делали срезы и окрашивали гематоксилином и эозином, как описано выше. Было измерено кол...

Watch this Scientific Journal Video about Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates at JoVE.com

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

We demonstrate a method to generate 3D breast cancer surrogates, which can be cultured using a perfusion bioreactor system to deliver oxygen and nutrients. Following growth, surrogates are fixed and processed to paraffin for evaluation of parameters of interest. The evaluation of one such parameter, cell density, is explained.

Получение и анализ<em&gt; In Vitro</em&gt; Трехмерное карциному груди Суррогаты

Three dimensional (3D) culture is a more physiologically relevant method to model cell behavior in vitro than two dimensional culture. Carcinomas, ...

preparation-analysis-vitro-three-dimensional-breast-carcinoma

Research

JoVE Journal

Bioengineering

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

10.6K Views.  University of Alabama at Birmingham. We demonstrate a method to generate 3D breast cancer surrogates, which can be cultured using a perfusion bioreactor system to deliver oxygen and nutrients. Following growth, surrogates are fixed and processed to paraffin for evaluation of parameters of interest. The evaluation of one such parameter, cell density, is explained.

Video: Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less aggressive breast tumors, the 5-year survival rate of TNBC patients is 77% due to their characteristic drug-resistant phenotype and metastatic burden. Toward this end, murine models have been established aimed at identifying novel therapeutic strategies limiting TNBC tumor growth and metastatic spread. This work describes a practical guide for the TNBC orthotopic model where MDA-MB-231 breast cancer cells suspended in a basement membrane matrix are implanted in the fourth mammary fat pad, which closely mimics the cancer cell behavior in humans. Measurement of tumors by caliper, lung metastasis assessment via in vivo and ex vivo imaging, and molecular detection are discussed. This model provides an excellent platform to study therapeutic efficacy and is especially suitable for the study of the interaction between the primary tumor and distal metastatic sites.

This work presets an advanced protocol to accurately assess tumor loading by detection of green fluorescent protein and bioluminescence signals as well as the integration of quantitative molecular detection technique.

Изучение Тройной отрицательный рак молочной железы Использование ортотопической модели рака молочной железы

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less ...

Cancer Research

Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts

Three-dimensional (3D) culture of organoids from tumor specimens of human patients and patient-derived xenograft (PDX) models of prostate cancer, referred to as patient-derived organoids (PDO), are an invaluable resource for studying the mechanism of tumorigenesis and metastasis of prostate cancer. Their main advantage is that they maintain the distinctive genomic and functional heterogeneity of the original tissue compared to conventional cell lines that do not. Furthermore, 3D cultures of PDO can be used to predict the effects of drug treatment on individual patients and are a step towards personalized medicine. Despite these advantages, few groups routinely use this method in part because of the extensive optimization of PDO culture conditions that may be required for different patient samples. We previously demonstrated that our prostate cancer bone metastasis PDX model, PCSD1, recapitulated the resistance of the donor patient&rsquo;s bone metastasis to anti-androgen therapy. We used PCSD1 3D organoids to characterize further the mechanisms of anti-androgen resistance. Following an overview of currently published studies of PDX and PDO models, we describe a step-by-step protocol for 3D culture of PDO using domed or floating basement membrane (e.g., Matrigel) spheres in optimized culture conditions. In vivo stitch imaging and cell processing for histology are also described. This protocol can be further optimized for other applications including western blot, co-culture, etc. and can be used to explore characteristics of 3D cultured PDO pertaining to drug resistance, tumorigenesis, metastasis and therapeutics.

Establishment and Analysis of Three-Dimensional 3D Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts

Three-dimensional cultures of patient BMPC specimens and xenografts of bone metastatic prostate cancer maintain the functional heterogeneity of their original tumors resulting in cysts, spheroids and complex, tumor-like organoids. This manuscript provides an optimization strategy and protocol for 3D culture of heterogeneous patient derived samples and their analysis using IFC.

Создание и анализ трехмерных (3D) органоидов, полученных из метастазов костной ткани рака простаты Исты и их Ксенотранспланты

Three-dimensional (3D) culture of organoids from tumor specimens of human patients and patient-derived xenograft (PDX) models of prostate cancer, referred ...

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Breast cancer stem cells (BCSCs) are cancer cells with inherited or acquired stem cell-like characteristics. Despite their low frequency, they are major contributors to breast cancer initiation, relapse, metastasis and therapy resistance. It is imperative to understand the biology of breast cancer stem cells in order to identify novel therapeutic targets to treat breast cancer. Breast cancer stem cells are isolated and characterized based on expression of unique cell surface markers such as CD44, CD24 and enzymatic activity of aldehyde dehydrogenase (ALDH). These ALDHhighCD44+CD24- cells constitute the BCSC population and can be isolated by fluorescence-activated cell sorting (FACS) for downstream functional studies. Depending on the scientific question, different in vitro and in vivo methods can be used to assess the functional characteristics of BCSCs. Here, we provide a detailed experimental protocol for isolation of human BCSCs from both heterogenous populations of breast cancer cells as well as primary tumor tissue obtained from breast cancer patients. In addition, we highlight downstream in vitro and in vivo functional assays including colony forming assays, mammosphere assays, 3D culture models and tumor xenograft assays that can be used to assess BCSC function.

This experimental protocol describes the isolation of BCSCs from breast cancer cell and tissue samples as well as the in vitro and in vivo assays that can be used to assess BCSC phenotype and function.

Выделение и функциональная оценка стволовых клеток рака молочной железы человека из образцов клеток и тканей

Breast cancer stem cells (BCSCs) are cancer cells with inherited or acquired stem cell-like characteristics. Despite their low frequency, they are major ...

Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds

Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of overall pediatric cancer deaths. The native tumor tissue is a complex three-dimensional (3D) microenvironment involving layers of cancerous and non-cancerous cells surrounded by an extracellular matrix (ECM). The ECM provides physical and biological support and contributes to disease progression, patient prognosis, and therapeutic response.
This paper describes a protocol for assembling a 3D scaffold-based system to mimic the neuroblastoma microenvironment using neuroblastoma cell lines and collagen-based scaffolds. The scaffolds are supplemented with either nanohydroxyapatite (nHA) or glycosaminoglycans (GAGs), naturally found at high concentrations in the bone and bone marrow, the most common metastatic sites of neuroblastoma. The 3D porous structure of these scaffolds allows neuroblastoma cell attachment, proliferation and migration, and the formation of cell clusters. In this 3D matrix, the cell response to therapeutics is more reflective of the in vivo situation.
The scaffold-based culture system can maintain higher cell densities than conventional two-dimensional (2D) cell culture. Therefore, optimization protocols for initial seeding cell numbers are dependent on the desired experimental timeframes. The model is monitored by assessing cell growth via DNA quantification, cell viability via metabolic assays, and cell distribution within the scaffolds via histological staining.
This model&#39;s applications include the assessment of gene and protein expression profiles as well as cytotoxicity testing using conventional drugs and miRNAs. The 3D culture system allows for the precise manipulation of cell and ECM components, creating an environment more physiologically similar to native tumor tissue. Therefore, this 3D in vitro model will advance the understanding of the disease pathogenesis and improve the correlation between results obtained in vitro, in vivo in&#160;animal models, and human subjects.

Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds

This paper lists the steps required to seed neuroblastoma cell lines on previously described three-dimensional collagen-based scaffolds, maintain cell growth for a predetermined timeframe, and retrieve scaffolds for several cell growth and cell behavior analyses and downstream applications, adaptable to satisfy a range of experimental aims.

Трехмерная биомиметическая модель нейробластомы in vitro с использованием скаффолдов на основе коллагена

Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of overall pediatric cancer deaths. The native tumor tissue is a ...

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research

Breast cancer is the leading cause of mortality in women. The growth of breast cancer cells and their subsequent metastasis is a key factor for its progression. Although the mechanisms involved in promoting breast cancer growth have been intensively studied using monocultures of breast cancer cells such as MCF-7 cells, the contribution of other cell types, such as vascular and lymphatic endothelial cells that are intimately involved in tumor growth, has not been investigated in depth. Cell-cell interaction plays a key role in tumor growth and progression. Neoangiogenesis, or the development of vessels, is essential for tumor growth, whereas the lymphatic system serves as a portal for cancer cell migration and subsequent metastasis. Recent studies provide evidence that vascular and lymphatic endothelial cells can significantly influence cancer cell growth. These observations imply a need for developing in vitro models that would more realistically reflect breast cancer growth processes in vivo. Moreover, restrictions in animal research require the development of ex vivo models to elucidate better the mechanisms involved.
This article describes the development of breast cancer spheroids composed of both breast cancer cells (estrogen receptor-positive MCF-7 cells) and vascular and/or lymphatic endothelial cells. The protocol describes a detailed step-by-step approach in creating dual-cell spheroids using two different approaches, hanging drop (gold standard and cheap) and 96-well U-bottom plates (expensive). In-depth instructions are provided for how to delicately pick up the formed spheroids to monitor growth by microscopic sizing and assessing viability using dead and live cell staining. Moreover, procedures to fix the spheroids for sectioning and staining with growth-specific antibodies to differentiate growth patterns in spheroids are delineated. Additionally, details for preparing spheroids with transfected cells and methods to extract RNA for molecular analysis are provided. In conclusion, this article provides in-depth instructions for preparing multi-cell spheroids for breast cancer research.

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research

Crosstalk between mammary epithelial cells and endothelial cells importantly contributes to breast cancer progression, tumor growth, and metastasis. In this study, spheroids have been made from breast cancer cells together with vascular and/or lymphatic endothelial cells and demonstrate their applicability as an in vitro system for breast cancer research.

Сфероиды эпителиальных и эндотелиальных клеток молочной железы как потенциальная функциональная модель in vitro для исследований рака молочной железы

Breast cancer is the leading cause of mortality in women. The growth of breast cancer cells and their subsequent metastasis is a key factor for its ...

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model

It is now well known that the cellular and tissue microenvironment are critical regulators influencing tumor initiation and progression. Moreover, the extracellular matrix (ECM) has been demonstrated to be a critical regulator of cell behavior in culture and homeostasis in vivo. The current approach of culturing cells on two-dimensional (2D), plastic surfaces results in the disturbance and loss of complex interactions between cells and their microenvironment. Through the use of three-dimensional (3D) culture assays, the conditions for cell-microenvironment interaction are established resembling the in vivo microenvironment. This article provides a detailed methodology to grow breast cancer cells in a 3D basement membrane protein matrix, exemplifying the potential of 3D culture in the assessment of cell invasion into the surrounding environment. In addition, we discuss how these 3D assays have the potential to examine the loss of signaling molecules that regulate epithelial morphology by immunostaining procedures. These studies aid to identify important mechanistic details into the processes regulating invasion, required for the spread of breast cancer.

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

This article provides detailed methodologies for the use of three-dimensional (3D) assays to quantify breast cancer cell invasion. Specifically, we discuss the procedures required to set up such assays, quantification, and data analysis, as well as methods to examine the loss of membrane integrity that occurs when cells invade.

Количественное определение клеток рака молочной железы инвазивности Использование трехмерной (3D) модель

It is now well known that the cellular and tissue microenvironment are critical regulators influencing tumor initiation and progression. Moreover, the ...

Medicine

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche

Bone is the most common site of breast cancer metastasis. Although it is widely accepted that the microenvironment influences cancer cell behavior, little is known about breast cancer cell properties and behaviors within the native microenvironment of human bone tissue.We have developed approaches to track, quantify and modulate human breast cancer cells within the microenvironment of cultured human bone tissue fragments isolated from discarded femoral heads following total hip replacement surgeries. Using breast cancer cells engineered for luciferase and enhanced green fluorescent protein (EGFP) expression, we are able to reproducibly quantitate migration and proliferation patterns using bioluminescence imaging (BLI), track cell interactions within the bone fragments using fluorescence microscopy, and evaluate breast cells after colonization with flow cytometry. The key advantages of this model include: 1) a native, architecturally intact tissue microenvironment that includes relevant human cell types, and 2) direct access to the microenvironment, which facilitates rapid quantitative and qualitative monitoring and perturbation of breast and bone cell properties, behaviors and interactions. A primary limitation, at present, is the finite viability of the tissue fragments, which confines the window of study to short-term culture. Applications of the model system include studying the basic biology of&#160;breast cancer and other bone-seeking malignancies within the metastatic niche, and developing therapeutic strategies to effectively target breast cancer cells in bone tissues.

Protocols are described for studying breast cancer cell migration, proliferation and colonization in a human bone tissue explant model system.

Методы культивирования бедренной кости человека тканевых эксплантов для изучения клеток рака молочной железы колонизации метастатического ниши

Bone is the most common site of breast cancer metastasis. Although it is widely accepted that the microenvironment influences cancer cell behavior, little ...

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Invasion of surrounding normal tissues is generally considered to be a key hallmark of malignant (as opposed to benign) tumors. For some cancers in particular (e.g., brain tumors such as glioblastoma multiforme and squamous cell carcinoma of the head and neck &#8211; SCCHN) it is a cause of severe morbidity and can be life-threatening even in the absence of distant metastases. In addition, cancers which have relapsed following treatment unfortunately often present with a more aggressive phenotype. Therefore, there is an opportunity to target the process of invasion to provide novel therapies that could be complementary to standard anti-proliferative agents. Until now, this strategy has been hampered by the lack of robust, reproducible assays suitable for a detailed analysis of invasion and for drug screening. Here we provide a simple micro-plate method (based on uniform, self-assembling 3D tumor spheroids) which has great potential for such studies. We exemplify the assay platform using a human glioblastoma cell line and also an SCCHN model where the development of resistance against targeted epidermal growth factor receptor (EGFR) inhibitors is associated with enhanced matrix-invasive potential. We also provide two alternative methods of semi-automated quantification: one using an imaging cytometer and a second which simply requires standard microscopy and image capture with digital image analysis.

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Invasion of surrounding normal tissues is a defining characteristic of malignant tumors. We provide here a simple, semi-automated micro-plate assay of invasion into a natural 3D biomatrix that has been exemplified with a number of models of advanced human cancers.

Трехмерная (3D) опухоли Сфероид Вторжение Пробирной

Invasion of surrounding normal tissues is generally considered to be a key hallmark of malignant (as opposed to benign) tumors. For some cancers in ...

Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation

Mammalian cell culture in monolayers is widely used to study various physiological and molecular processes. However, this approach to study growing cells often generates unwanted artifacts. Therefore, cell culture in a three-dimensional (3D) environment, often using extracellular matrix components, emerged as an interesting alternative due to its close similarity to the native in vivo tissue or organ. We developed a 3D cell culture system using two compartments, namely (i) a central compartment containing cancer cells embedded in a collagen gel acting as a pseudo-primary macrospherical tumor and (ii) a peripheral cell-free compartment made of a fibrin gel, i.e. an extracellular matrix component different from that used in the center, in which cancer cells can migrate (invasion front) and/or form microspherical tumors representing secondary or satellite tumors. The formation of satellite tumors in the peripheral compartment is remarkably correlated to the known aggressiveness or metastatic origin of the native tumor cells, which makes this 3D culture system unique. This cell culture approach might be considered to assess cancer cell invasiveness and motility, cell-extracellular matrix interactions and as a method to evaluate anti-cancer drug properties.

Cancer cells are embedded in a collagen gel and then sandwiched in an acellular fibrin gel to generate a 3D culture system in which the invasiveness and formation of satellite tumors may be monitored.

Трехмерный культура анализа для изучения раковых клеток инвазивности и Satellite Опухоль Формирование

Mammalian cell culture in monolayers is widely used to study various physiological and molecular processes. However, this approach to study growing cells ...

Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks

Bioprinting is emerging as a promising tool to fabricate 3D human cancer models that better recapitulate critical hallmarks of in vivo tissue architecture. In current layer-by-layer extrusion bioprinting, individual cells are extruded in a bioink together with complex spatial and temporal cues to promote hierarchical tissue self-assembly. However, this biofabrication technique relies on complex interactions among cells, bioinks and biochemical and biophysical cues. Thus, self-assembly may take days or even weeks, may require specific bioinks, and may not always occur when there is more than one cell type involved. We therefore developed a technique to directly bioprint pre-formed 3D breast epithelial spheroids in a variety of bioinks. Bioprinted pre-formed 3D breast epithelial spheroids sustained their viability and polarized architecture after printing. We additionally printed the 3D spheroids onto vascular endothelial cell networks to create a co-culture model. Thus, the novel bioprinting technique rapidly creates a more physiologically relevant 3D human breast model at lower cost and with higher flexibility than traditional bioprinting techniques. This versatile bioprinting technique can be extrapolated to create 3D models of other tissues in additional bioinks.

The goal of this protocol is to directly bioprint breast epithelial cells as multicellular spheroids onto pre-formed endothelial networks to rapidly create 3D breast-endothelial co-culture models which can be used for drug screening studies.

Получение и анализ

Резюме

Смотреть дополнительные видео

PLAYLIST